Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ratnam S. Seelan, Partha Mukhopadhyay, M. Michele Pisano & Robert M. Greene. (2018) Effects of 5-Aza-2′-deoxycytidine (decitabine) on gene expression. Drug Metabolism Reviews 50:2, pages 193-207.
Read now
Read now
Christian Huisman, Monique GP van der Wijst, Fahimeh Falahi, Juul Overkamp, Gellért Karsten, Martijn M Terpstra, Klaas Kok, Ate GJ van der Zee, Ed Schuuring, G Bea A Wisman & Marianne G Rots. (2015) Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs. Epigenetics 10:5, pages 384-396.
Read now
Read now
Articles from other publishers (18)
Jianying Tian, Haiming Xu, Yawen Zhang, Xinchen Shi, Wencheng Wang, Huanmin Gao & Yongyi Bi. (2019) SAM targeting methylation by the methyl donor, a novel therapeutic strategy for antagonize PFOS transgenerational fertilitty toxicity. Ecotoxicology and Environmental Safety 184, pages 109579.
Crossref
Crossref
Joel M Michalski, Elizabeth R Lyden, Andrea J Lee, Zaid S Al-Kadhimi, Lori J Maness, Krishna Gundabolu & Vijaya Raj Bhatt. (2019) Intensity of chemotherapy for the initial management of newly diagnosed acute myeloid leukemia in older patients. Future Oncology 15:17, pages 1989-1995.
Crossref
Crossref
Jessica Tang, Nicholas Pulliam, Ali Özeş, Aaron Buechlein, Ning Ding, Harold Keer, Doug Rusch, Heather O'Hagan, M. Sharon Stack & Kenneth P. Nephew. (2018) Epigenetic Targeting of Adipocytes Inhibits High-Grade Serous Ovarian Cancer Cell Migration and Invasion. Molecular Cancer Research 16:8, pages 1226-1240.
Crossref
Crossref
Richard Daifuku, Sheila Grimes & Murray Stackhouse. (2018) NUC041, a Prodrug of the DNA Methytransferase Inhibitor 5-aza-2′,2′-Difluorodeoxycytidine (NUC013), Leads to Tumor Regression in a Model of Non-Small Cell Lung Cancer. Pharmaceuticals 11:2, pages 36.
Crossref
Crossref
Richard Daifuku, Zhenbo Hu & Yogen Saunthararajah. (2017) 5-aza-2′,2′-Difluoro Deoxycytidine (NUC013): A Novel Nucleoside DNA Methyl Transferase Inhibitor and Ribonucleotide Reductase Inhibitor for the Treatment of Cancer. Pharmaceuticals 10:3, pages 65.
Crossref
Crossref
Jadd Shelton, Xiao Lu, Joseph A. Hollenbaugh, Jong Hyun Cho, Franck Amblard & Raymond F. Schinazi. (2016) Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs. Chemical Reviews 116:23, pages 14379-14455.
Crossref
Crossref
Giuseppe Costa, Viviana Barra, Laura Lentini, Danilo Cilluffo & Aldo Di Leonardo. (2016) DNA demethylation caused by 5-Aza-2′-deoxycytidine induces mitotic alterations and aneuploidy. Oncotarget 7:4, pages 3726-3739.
Crossref
Crossref
Kumiko Ueda, Mika Hosokawa & Seigo Iwakawa. (2015) Cellular Uptake of Decitabine by Equilibrative Nucleoside Transporters in HCT116 Cells. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 38:8, pages 1113-1119.
Crossref
Crossref
Jing Lai, Weiwei Nie, Wenwen Zhang, Yucai Wang, Ruilian Xie, Yanru Wang, Jun Gu, Jing Xu, Wei Song, Fang Yang, Guichun Huang, Peng Cao & Xiaoxiang Guan. (2014) Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast cancer. Oncotarget 5:16, pages 6909-6922.
Crossref
Crossref
Nicholas Hatzirodos, Katja Hummitzsch, Helen F. Irving-Rodgers & Raymond J. Rodgers. (2014) Transcriptome Profiling of the Theca Interna in Transition from Small to Large Antral Ovarian Follicles. PLoS ONE 9:5, pages e97489.
Crossref
Crossref
Sarah M. Leonard, Tracey Perry, Ciar?n B. Woodman & Pamela Kearns. (2014) Sequential Treatment with Cytarabine and Decitabine Has an Increased Anti-Leukemia Effect Compared to Cytarabine Alone in Xenograft Models of Childhood Acute Myeloid Leukemia. PLoS ONE 9:1, pages e87475.
Crossref
Crossref
Claire Westerland & Tom C. Karagiannis. 2014. Molecular mechanisms and physiology of disease. Molecular mechanisms and physiology of disease
81
112
.
Philip C. Logan, Anna P. Ponnampalam, Michael Steiner & Murray D. Mitchell. (2013) Effect of cyclic AMP and estrogen/progesterone on the transcription of DNA methyltransferases during the decidualization of human endometrial stromal cells. MHR: Basic science of reproductive medicine 19:5, pages 302-312.
Crossref
Crossref
Jeffery M. Klco, David H. Spencer, Tamara L. LamprechtShawn M. SarkariaTodd Wylie, Vincent Magrini, Jasreet Hundal, Jason Walker, Nobish Varghese, Petra Erdmann-Gilmore, Cheryl F. Lichti, Matthew R. Meyer, R. Reid Townsend, Richard K. Wilson, Elaine R. Mardis & Timothy J. Ley. (2013) Genomic impact of transient low-dose decitabine treatment on primary AML cells. Blood 121:9, pages 1633-1643.
Crossref
Crossref
Juan Liu, Yi-Shan Xie, Fu-Liang Wang, Li-Jun Zhang, Yan Zhang & He-Sheng Luo. (2013) Cytotoxicity of 5-Aza-2′-deoxycytidine against gastric cancer involves DNA damage in an ATM-P53 dependent signaling pathway and demethylation of P16INK4A. Biomedicine & Pharmacotherapy 67:1, pages 78-87.
Crossref
Crossref
Angela Nebbioso, Vincenzo Carafa, Rosaria Benedetti & Lucia Altucci. (2012) Trials with ‘epigenetic’ drugs: An update. Molecular Oncology 6:6, pages 657-682.
Crossref
Crossref
Sebastian Bultmann, Robert Morbitzer, Christine S. Schmidt, Katharina Thanisch, Fabio Spada, Janett Elsaesser, Thomas Lahaye & Heinrich Leonhardt. (2012) Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Research 40:12, pages 5368-5377.
Crossref
Crossref
Kamaleshwar P. Singh, Justin Treas, Tulika Tyagi & Weimin Gao. (2012) DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells. Cancer Letters 316:1, pages 62-69.
Crossref
Crossref